BETTELLI, Stefania Raffaella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.713
AS - Asia 3.793
EU - Europa 3.768
SA - Sud America 580
AF - Africa 97
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 6
Totale 16.964
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.582
SG - Singapore 1.220
GB - Regno Unito 1.029
CN - Cina 919
IT - Italia 717
HK - Hong Kong 454
BR - Brasile 437
VN - Vietnam 433
DE - Germania 402
SE - Svezia 356
IE - Irlanda 287
FI - Finlandia 208
UA - Ucraina 160
RU - Federazione Russa 153
FR - Francia 137
TR - Turchia 120
IN - India 112
KR - Corea 81
JP - Giappone 75
ID - Indonesia 70
CA - Canada 67
BG - Bulgaria 62
BD - Bangladesh 55
AR - Argentina 52
NL - Olanda 50
PL - Polonia 41
MX - Messico 40
IQ - Iraq 34
PK - Pakistan 29
ZA - Sudafrica 29
BE - Belgio 22
CO - Colombia 22
LT - Lituania 21
AT - Austria 20
MY - Malesia 19
AE - Emirati Arabi Uniti 18
CL - Cile 17
CZ - Repubblica Ceca 16
SA - Arabia Saudita 16
VE - Venezuela 16
UZ - Uzbekistan 15
EC - Ecuador 14
ES - Italia 14
EG - Egitto 13
IR - Iran 11
MA - Marocco 11
TH - Thailandia 11
TW - Taiwan 11
CH - Svizzera 10
PH - Filippine 10
RO - Romania 10
AZ - Azerbaigian 9
NP - Nepal 9
DK - Danimarca 8
JO - Giordania 8
KE - Kenya 8
PY - Paraguay 8
TN - Tunisia 8
IL - Israele 7
LB - Libano 7
PE - Perù 7
AU - Australia 6
BH - Bahrain 6
CR - Costa Rica 6
DZ - Algeria 5
EU - Europa 5
GR - Grecia 5
PT - Portogallo 5
RS - Serbia 5
BO - Bolivia 4
GA - Gabon 4
GE - Georgia 4
KZ - Kazakistan 4
LK - Sri Lanka 4
NO - Norvegia 4
TZ - Tanzania 4
AM - Armenia 3
BA - Bosnia-Erzegovina 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
DO - Repubblica Dominicana 3
EE - Estonia 3
GT - Guatemala 3
OM - Oman 3
PS - Palestinian Territory 3
SY - Repubblica araba siriana 3
AL - Albania 2
AO - Angola 2
BB - Barbados 2
CY - Cipro 2
HN - Honduras 2
HU - Ungheria 2
JM - Giamaica 2
ME - Montenegro 2
MK - Macedonia 2
MT - Malta 2
NG - Nigeria 2
QA - Qatar 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
Totale 16.936
Salva come PNG Salva come JPEG
Città #
Ashburn 849
Singapore 828
Fairfield 817
Santa Clara 784
Southend 660
Chandler 497
Hong Kong 444
Woodbridge 438
Houston 358
San Jose 358
Seattle 345
Ann Arbor 294
Dublin 286
Cambridge 284
Wilmington 266
Jacksonville 263
Dearborn 260
Nyköping 226
Beijing 216
Hefei 202
London 167
Los Angeles 158
Chicago 157
Helsinki 144
Ho Chi Minh City 143
New York 126
The Dalles 116
Dallas 111
Modena 111
Council Bluffs 109
Hanoi 101
Munich 83
Salt Lake City 78
Seoul 75
Izmir 68
Tokyo 66
Lauterbourg 61
Princeton 60
San Diego 60
Sofia 57
Milan 53
Moscow 52
Eugene 50
Jakarta 49
Shanghai 46
Bologna 42
São Paulo 42
Orem 41
Tampa 38
Rome 36
Buffalo 35
Elk Grove Village 33
Fremont 32
Falls Church 31
Turku 27
Warsaw 26
Columbus 25
Frankfurt am Main 25
Bremen 24
Sterling 24
Dong Ket 23
Ottawa 22
Phoenix 20
Brussels 18
Mexico City 18
Lahore 17
Redwood City 17
Denver 16
Haiphong 16
Norwalk 16
Brooklyn 15
Dhaka 15
Redondo Beach 15
Boston 14
Lancaster 14
Nuremberg 14
Da Nang 13
Johannesburg 13
Mumbai 13
Parma 13
Stockholm 13
Naples 12
Tashkent 12
Atlanta 11
Baghdad 11
Brno 11
Chennai 11
Lansdale 11
Manchester 11
Hyderabad 10
Santiago 10
Amsterdam 9
Baku 9
Boardman 9
Des Moines 9
Grafing 9
Hải Dương 9
Jeddah 9
Kunming 9
Nanjing 9
Totale 11.983
Salva come PNG Salva come JPEG
Nome #
Comparison of HER-2 and hormone receptor expression in primary breast cancers and asynchronous paired metastases: impact on patient management 416
Alterations of 9p21 analysed by FISH and MLPA distinguish atypical spitzoid melanocytic tumours from conventional Spitz's nevi but do not predict their biological behaviour 414
Assessment of freezing effects and diagnostic potential of BioBank healthy and neoplastic breast tissues through HR-MAS NMR spectroscopy 412
Poorly differentiated clusters (PDC) in colorectal cancer: What is and ought to be known. 408
Atypical Spitzoid melanocytic tumors:A morphological, mutational, and FISH analysis 407
Cytomegalovirus infection of the upper gastrointestinal tract: a clinical and pathological study of 30 cases. 397
Predictors of human epidermal growth factor receptor 2 fluorescence in-situ hybridisation amplification in immunohistochemistry score 2+ infiltrating breast cancer: a single institution analysis. 378
Differential molecular pathways expression in HER2 positive early breast cancer according to hormone receptor status. 373
Clinical and molecular analysis of long-term HER2 positive metastatic breast cancer survivors. 372
Mutational Profile of Metastatic Breast Cancer Tissue in Patients Treated with Exemestane Plus Everolimus 352
Proteomics Analysis of Formalin-Fixed Paraffine-Embedded Tissue Reveals Key Proteins Related to Lung Dysfunction in Idiopathic Pulmonary Fibrosis. 346
Quick assessment of cell-free DNA in seminal fluid and fragment size for early non-invasive prostate cancer diagnosis 335
Epidermal growth factor receptor gene copy number, K-ras mutation and pathological response to preoperative cetuximab, 5-FU and radiation therapy in locally advanced rectal cancer.. 334
Molecular Profile, as detected with Mass-Array Spectrometry (Sequenom platform), in primary and metastatic breast carcinoma treated with Exemestane + Everolimus 332
Clinical and molecular predictors of long-term response in HER2 positive metastatic breast cancer patients. 318
Prediction of distant recurrence in resected stage I and II lung adenocarcinoma 315
Analysis of KRAS, NRAS, PIK3CA, and BRAF mutational profile in poorly differentiated clusters of KRAS-mutated colon cancer 310
Modulation of Mutational Landscape in HER2-Positive Breast Cancer after Neoadjuvant Chemotherapy 309
Overall survival in patients with lung adenocarcinoma harboring "niche" mutations: an observational study 308
Differential gene expression patterns in HER2 positive metastatic breast cancer patients according to hormone receptor status 307
Discordance in receptor status between primary and recurrent breast cancer has a prognostic impact: a single Institution analysis 306
Molecular profile in primary and metastatic breast cancer treated with Exemestane and Everolimus. 299
Durable remission in a patient with leptomeningeal relapse of a MYC/BCL6-positive double-hit DLBCL treated with lenalidomide monotherapy 296
Loss of HER2 positivity and prognosis after neoadjuvant therapy in HER2-positive breast cancer patients 291
ASSESSMENT OF FREEZING EFFECTS AND DIAGNOSTIC POTENTIAL OF BIOBANK HEALTHY AND NEOPLASTIC BREAST TISSUES THROUGH HR-MAS NMR SPECTROSCOPY 286
Alveolar rhabdomyosarcoma of the uterine cervix. A case report confirmed by FKHR break-apart rearrangement using a fluorescence in situ hybridization probe on paraffin-embedded tissues. 285
Expression of estrogen receptor in hemangioma of the uterine cervix: Reports of three cases and review of the literature 283
Does HPV play a role in the etiopathogenesis of ameloblastoma? An immunohistochemical, in situ hybridization and polymerase chain reaction study of 18 cases using laser capture microdissection 283
Double-blind, placebo-controlled, multicenter, randomized, phase IIb neoadjuvant study of letrozole-lapatinib in postmenopausal hormone receptor-positive, human epidermal growth factor receptor 2-negative, operable breast cancer 274
Cerebrospinal fluid cytology in a case of primary diffuse leptomeningeal and pineal melanocytic lesion, with histological confirmation 271
Prognostic role of EGFR gene copy number and KRAS mutation in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy. 267
Predictors of HER2 gene amplification in immunohistochemistry score 2+ Early Breast Cancer according to 2018 ASCO/CAP guidelines: a single institution analysis. 261
Prospective biomarker analysis of the randomized CHER-LOB study evaluating the dual anti-HER2 treatment with trastuzumab and lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive breast cancer 258
Differential gene expression patterns in HER2 positive metastatic breast cancer patients according to hormone receptor status. 258
Clinical impact and prognostic role of KRAS/BRAF/PIK3CA mutations in stage I colorectal cancer 252
35. PREDICTORS OF HER2 FISH POSITIVITY IN PRIMARY BREAST CANCER DIAGNOSIS SCORED 2+ WITH IHC: RESULTS OF A SINGLE INSTITUTION ANALYSIS 251
Detection of human papillomavirus DNA in urinary bladder carcinoma by in situ hybridization 248
EGFR polysomy in squamous cell carcinoma of the thyroid. Report of two cases and review of the literature 248
Prognostic impact of estrogen receptor (ER) level changes during progression for patients with both ER-positive (ER+) primary breast cancer and paired recurrence 245
Prediction of Distant Recurrence-Free Survival in Resectable Lung Adenocarcinoma. 245
Change in HER2 Status in HER2 Positive Operable Breast Cancer Patients Treated with Neoadjuvant Chemotherapy with or without Anti-HER2 Therapy: Analysis of Two Consecutive Cohorts 238
Real-World Data and Clinical Implications of Next-Generation Sequencing (NGS)-Based Analysis in Metastatic Breast Cancer Patients 237
Trans-CHER-Lob: A Biomarker Analysis of the Randomized Phase II Study of Neoadjuvant Chemotherapy Plus Trastuzumab, Lapatinib or Combined Trastuzumab and Lapatinib in HER2 Positive Operable Breast Cancer. 235
The prognostic role of c-kit protein expression in resected large cell neuroendocrine carcinoma of the lung 232
Microsatellite and EGFR, HER2 and K-RAS analyses in sclerosing hemangioma of the lung 231
High-Resolution Melting is a sensitive, cost-effective, time-saving technique for BRAF V600E detection in thyroid FNAB washing fluid: a prospective cohort study 224
Preoperative letrozole plus lapatinib/placebo for HR+/HER2 negative operable breast cancer: biomarker analyses of the randomized phase II LET-LOB study 220
COMPARISON OF HER-2 STATUS IN PRIMARY BREAST CANCER AND METASTATIC SITES: RESULTS FROM A SINGLE INSTITUTION ANALYSIS 220
Correlation between CD133 expression and mgmt status in recurrences melanoma 213
CtDNA-guided rechallenge with anti-EGFR therapy in RASwt metastatic colorectal cancer: Evidence from clinical practice 207
Cell of origin (COO), BCL2/MYC status and IPI define a group of patients with Diffuse Large B-cell Lymphoma (DLBCL) with poor prognosis in a real-world clinical setting 207
Deepening the knowledge of ros1 rearrangements in non-small cell lung cancer: Diagnosis, treatment, resistance and concomitant alterations 206
Next Generation Sequencing (NGS): a possible game changer in metastatic breast cancer 201
FISH analysis in cell touch preparations and cytological specimens from formalin-fixed fetal autopsies 191
Prognostic role of HER2 loss after neoadjuvant therapy in patients with HER2-positive operable breast cancer 187
Evaluation of the effects of cryopreservation on Modena Biobank tissue samples through HR-MAS NMR 182
Histopathological variables in liver metastases of patients with stage IV colorectal cancer: potential prognostic relevance of poorly differentiated clusters 178
KRAS, NRAS, BRAF mutations and high counts of poorly differentiated clusters of neoplastic cells in colorectal cancer: Observational analysis of 175 cases 175
Clinicopathological, cytogenetic, and molecular profiles of primary cutaneous diffuse large B-cell lymphomas 164
Morphological analysis of three extrathoracic bronchogenic cysts simulating neoplasms 151
Unexpected tumor response to palliative pelvic radiotherapy in mismatch repair-deficient advanced prostate cancer: a case report 144
Rare Driver Mutations in Advanced, Oncogene-Addicted Non-Small Cell Lung Cancer: A North Italian, Real-World, Registry Experience 125
Correction to: Prognostic role of EGFR gene copy number and KRAS mutation in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy (British Journal of Cancer, (2010), 103, 7, (1019-1024), 10.1038/sj.bjc.6605853) 77
A Novel Molecular Profile of Hormone-Sensitive Prostate Cancer Defines High Risk Patients 71
A new digital droplet PCR method for looking at epigenetics in diffuse large B‐cell lymphomas: The role of BMI1, EZH2, and USP22 genes 31
Totale 17.097
Salva come PNG Salva come JPEG
Categoria #
all - tutte 61.782
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.782
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021216 0 0 0 0 0 0 0 0 0 0 114 102
2021/20221.179 52 128 94 71 40 91 54 58 121 123 202 145
2022/20231.520 149 164 117 122 121 178 35 115 400 13 46 60
2023/2024937 18 53 47 91 160 68 194 114 23 21 55 93
2024/20252.807 77 30 78 217 565 446 201 159 313 138 220 363
2025/20265.587 410 192 492 727 1.147 412 732 313 555 505 102 0
Totale 17.097